|
Summary
March 2007, Vol. 11, No. 3, Pages 273-278
, DOI 10.1517/14728222.11.3.273
Mechanisms of action of statins in strokeJosé Tuñón1Associate Chief, Fundación Jiménez Díaz, Department of Cardiology, Avenida Reyes Católicos 2, 28040 Madrid, Spain 2Associate Professor, Autónoma University, Madrid, Spain 3Researcher, Fundación Jiménez Díaz, Vascular Research Laboratory, Avenida Reyes Católicos 2, 28040 Madrid, Spain 4Director, Fundación Jiménez Díaz, Vascular Research Laboratory, Avenida Reyes Católicos 2, 28040 Madrid, Spain. jegido@fjd.es 5Professor of Medicine, Autónoma University, Madrid, Spain †  Author for correspondenceStatins decrease the incidence of cardiovascular events and death in patients with coronary artery disease. Moreover, the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study has recently demonstrated that high-dose atorvastatin may also reduce the recurrence of stroke in patients with previous stroke or transitory ischemic attack. Forward Links to Citing ArticlesRaquel Rodrigues-Díez, Gisselle Carvajal-González, Elsa Sánchez-López, Juan Rodríguez-Vita, Raúl Rodrigues Díez, Rafael Selgas, Alberto Ortiz, Jesús Egido, Sergio Mezzano, Marta Ruiz-Ortega. (2008) Pharmacological Modulation of Epithelial Mesenchymal Transition Caused by Angiotensin II. Role of ROCK and MAPK Pathways. Pharmaceutical Research 25:10, 2447-2461 Online publication date: 1-Nov-2008. CrossRef |
|
TOC Alert